RELATLIMAB vs REMIFENTANIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RELATLIMAB vs REMIFENTANIL: Safety Overview
| Metric | RELATLIMAB | REMIFENTANIL |
|---|---|---|
| Total FAERS Reports | 177 | 2,733 |
| Deaths Reported | 29 | 210 |
| Death Rate | 16.4% | 7.7% |
| Hospitalizations | 145 | 995 |
| Average Patient Age | 64.5 yrs | 50.3 yrs |
| % Female Patients | 34.6% | 48.2% |
| FDA Approval Date | N/A | Jan 16, 2018 |
| Manufacturer | N/A | Fresenius Kabi USA, LLC |
| Route | N/A | INTRAVENOUS |
| Marketing Status | N/A | Prescription |